RedChip Investor Webinar with Calidi Biotherapeutics (NYSE American: CLDI)

Calidi Biotherapeutics (NYSE American: CLDI) invites investors to an exclusive live webinar on November 19 at 4:15 p.m. ET, featuring CEO Eric Poma, Ph.D. Learn how Calidi’s proprietary RedTail™ platform—an engineered, systemically delivered viral therapy—aims to transform the treatment of metastatic and difficult-to-treat tumors by delivering potent genetic medicines throughout the body. The presentation will highlight compelling preclinical data, the Company’s lead candidate CLD-401, a strong clinical and strategic outlook, and upcoming value-driving milestones, followed by a live Q&A session.